# GenapSys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genapsys

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.genapsys.com
- Total disclosed funding: $155M
- Latest round: Series D (Feb 8, 2021)
- Investors on record: 8

## About

Founded in 2010 and based in California, US, Genapsys, Inc. operates as a biotechnology company that develops a novel DNA sequencing technology and detection system for applied genomic testing and medical sequencing. Hesaam Esfandyarpour is the CEO, chairman, and founder of the company. In May 2021, the firm raised USD 70 million in Series D funding from Farallon Capital Management, PBM Capital Group, and Soleus Capital Management.

The company provides GenapSys™ Sequencer, an electrical-based platform that enables to detect sequencing. This DNA-sequencing technology is used for research and testing genetic diseases, cancer, and microbes. The organization's platform enables academic and clinical researchers, molecular pathologists, and other physicians to gain easy access to genomic sequencing. 

GenapSys plans to use the May 2021 funding to continue advancing its semiconductor-based NGS platform.

## Funding rounds

- Series D, Feb 8, 2021, $29M — PBM Capital Group, Farallon Capital Management, Soleus Capital
- Series C, Nov 20, 2019, $90M — Foresite Capital
- Series B, Nov 14, 2013, $36M — IPV Capital Partners, Stanford University, Decheng Capital, Nantian Yingfu Taike Capital

## Investors

- IPV Capital Partners (https://capitalatlas.ai/funds/ipv-capital-partners) — Series B
- Stanford University — Series B
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series B
- Nantian Yingfu Taike Capital — Series B
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series C
- PBM Capital Group (https://capitalatlas.ai/funds/pbm-capital-group) — Series D
- Farallon Capital Management (https://capitalatlas.ai/funds/farallon-capital-management) — Series D
- Soleus Capital (https://capitalatlas.ai/funds/soleus-capital) — Series D